News Releases
You are browsing the news release archive.
2009
CAMH and MaRS Innovation partner on innovative approach to nicotine addiction
December 17, 2009
Toronto, December 17, 2009 – Grappling with nicotine addiction is never easy, but a new drug therapy – developed by Dr. Fang Liu at the Centre for Addiction and Mental Health (CAMH) – brings promise to one of our great public health challenges. The experimental medication in development at Dr. Liu’s lab targets the brain …
CAMH and MaRS Innovation partner on innovative approach to nicotine addiction
Toronto, December 17, 2009 – Grappling with nicotine addiction is never easy, but a new drug therapy – developed by Dr. Fang Liu at the Centre for Addiction and Mental Health (CAMH) – brings promise to one of our great public health challenges. The experimental medication in development at Dr. Liu’s lab targets the brain …
Making (brain) waves beyond the holiday season
December 10, 2009
Toronto start-up turns thought-controlled technology into fun, interactive products & events Toronto, December 10, 2009 — Brain-controlled games are among 2009’s hottest holiday toys, but the minds behind Canadian upstart and MaRS client InteraXon have been pushing the frontier of brainwave technology through their engaging products and events for years. In the last year, the …
New company enters growing brain fitness market
December 2, 2009
MaRS teams up with Baycrest’s world-renowned cognitive scientists Toronto, December 2, 2009 – One of the world’s leading cognitive science institutes announced today it has created a new company with MaRS, Canada’s premiere innovation centre, to develop and market brain fitness products to help adults extend their memory and cognitive abilities longer in the lifespan. …
MaRS Innovation and CDRD Announce Strategic Collaboration
November 30, 2009
Toronto and Vancouver, November 30, 2009 – MaRS Innovation (MI) and the Centre for Drug Research and Development (CDRD) are pleased to announce that they have entered into an agreement to collaborate on projects of mutual interest with a goal to advance and commercialize early-stage health-related discoveries. “We are excited about our partnership with the …
